The FDA has approved a generic form of the neuropathic pain drug Lyrica, according to MedPage Today report.
Lupin, based in India, has been granted approval to manufacture eight oral strengths of the generic formulation.
Pain Management Specialist Dr. John Keel Joins New England Baptist Hospital
Opposition Threatens Kentucky Drug Abuse Bill
Lupin, based in India, has been granted approval to manufacture eight oral strengths of the generic formulation.
Related Articles on Pain Management:
myoscience Receives FDA Clearance for Pain Management DevicePain Management Specialist Dr. John Keel Joins New England Baptist Hospital
Opposition Threatens Kentucky Drug Abuse Bill